
Cefuroxime (2Nd Gen) Tablets/Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets/Capsules
Available Strengths: 250 mg, 500 mg
Reference Brands: Ceftin, Zinacef(US & EU)
Category: Antibiotics
Cefuroxime (2nd Gen) Tablets/Capsules is available in Oral Tablets/Capsules and strengths such as 250 mg, 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cefuroxime (2nd Gen) Tablets/Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefuroxime (2nd Gen) Tablets/Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Cefuroxime (2nd generation cephalosporin) tablets and capsules are approved in both the EU and US for treating respiratory, urinary, and skin bacterial infections. In the EU, brands like Ceftin and Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans. For regulatory support, compliance, and registration, visit PharmaTradz. We support seamless market access for cefuroxime, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Cefradine
Strength:
250 mg, 500 mg
Form: Tablets
Reference Brands: Velosef (USA/EU), Intracef (EU)
View DetailsDaptomycin
Strength:
350 mg, 500 mg
Form: Injection
Reference Brands: Cubicin (USA/EU), Dapzura RT (USA)
View DetailsProcaine Penicillin
Strength:
600,000 IU, 1,200,000 IU
Form: Injection
Reference Brands: Farmaproina (EU), Wycillin (USA)
View DetailsIsoniazid + Rifampicin
Strength:
300mg+150mg, 100mg+150mg
Form: Capsules / Tablet
Reference Brands: Rifamate (USA), IsonaRif (USA), Rifinah(UK)
View DetailsQuick Response Guaranteed | Verified Suppliers